THE BURDEN OF DISEASE AND POTENTIAL LIFE LOSS DUE TO HIV INFECTION
https://doi.org/10.22328/2077-9828-2017-9-3-91-97
Abstract
The WHO global burden of disease study methods were used to estimate the burden of HIV infection in Omsk region. Such estimates as DALY, YLL and YLD were used. Both incidence and mortality in the population of Omsk region had a trend to increase during 2011–2015 from 46,8 to 123,5 and from 5,5 to 17,2 per 100 000 population respectively. The burden of HIV infection in Omsk region in 2015 has risen 4,9 fold compared with 2011 and was 12 735,1 DALY, burden of mortality due to HIV infection, has risen 5,6 fold to 11 763,1 YLL and burden of HIV sequel has risen 1,9 fold to 972,0 YLD. The substantial part of burden of mortality was on males and it has risen from 67,2% to 76,9%. And the greatest part of this burden in males was on ages 30–34 years in 2011 and on 35–39 in 2015; the same was seen in females — 25–29 years in 2011 and 30–34 in 2015. The burden of mortality per one death was 52,5 years and was bigger in females. The study of HIV infection burden has a great social and economic meaning, and it is a way to choose foreground ways of prophylactics.
About the Authors
A. I. Blokh
Omsk State Medical University of the Ministry of Health of the Russian Federation
Russian Federation
Russian Federation
O. A. Pasechnik
Omsk State Medical University of the Ministry of Health of the Russian Federation
Russian Federation
Russian Federation
References
1. Сабгайда Т.П., Протасова Н.П., Артюхов И.П. Адаптация расчета DALY для анализа потерь здоровья населения вследствие сердечно-сосудистых болезней, не приводящих к смертельному исходу // Социальные аспекты здоровья населения. 2015. № 1 (41). URL: http://vestnik.mednet.ru/content/view/643/30/lang,ru/. [Sabgayda T.P., Protasova N.P., Artyukhov I.P. Adaptation of the calculation of DALY for the analysis of health loss due to cardiovascular diseases leading to death. Social Aspects of Population Health, 2015, No. 1 (41), URL: http://vestnik.mednet.ru/content/view/643/30/lang,ru/ (In Russ.)].
2. Murray C.J.L., Barber R.M., Foreman K.J., Ozgoren A.A. et al. Global, regional and nationaldisability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition. Lancet, 2015, Vol. 386, No. 10 009, pp. 2145–2191.
3. Методические рекомендации по использованию показателя «Потерянные годы потенциальной жизни» для обоснования приоритетных проблем здоровья населения России на федеральном, региональном и муниципальном уровнях // И.А.Красильников, А.Е.Иванова, В.Г.Семенов, Т.П.Сабгайда, Г.Н.Евдокушкина. М.: ЦНИИОЗ, 2014. 32 с. [Methodical recommendations on the level of «Lost years of poten- tial life» to justify the priority health problems of the population of Russia at the Federal, regional and municipal level. Ed. I.A.Krasilnikov, A.E.Ivanova, V.G.Semenov, T.P.Sabgayda, G.N.Evdokushkina. Moscow: ZNIIS, 2014. 32 p. (In Russ.)].
4. WHO. HIV/AIDS/Fact sheet. URL: http://www.who.int/mediacentre/factsheets/fs360/en/.
5. WHO. Disability weights, discounting and age weighting of DALYs. URL: http://www.who.int/healthinfo/global_burden_disease/ daly_disability_weight/en/.
6. Калачева Г.А., Пасечник О.А., Левахина Л.И., Матущенко Е.А. Эпидемические проявления ВИЧ-инфекции на территории Сибирского федерального округа: описательное исследование // ВИЧ-инфекция и иммуносупрессии. 2015. Т. 7, № 3. С 110–117. [Kalacheva G.A., Pasechnik O.A., Levakina L.I., Matuschenko E.A. Epidemic of HIV-infection on the territory of the Siberian Federal district: a descriptive study. HIV Infection and Immunosuppressive Disorders, 2015, Vol. 7, No. 3, pp. 110–117. (In Russ.)].
7. Эпидемиологические проявления ВИЧ-инфекции на территории Омской области за 2015 год. Информационный бюллетень / Под ред. О.И.Назаровой. Омск: БУЗ Омской области «Центр по профилактике и борьбе со СПИД и инфекционными заболеваниями», 2016. 25 с. [Epidemiological manifestations of HIV infection in the territory of Omsk region in 2015. Newsletter. Ed. O.I.Nazarova. Omsk: Omsk Center for Prevention and Control of AIDS and Infectious Diseases, 2016, 25 p. (In Russ.)].
8. Эпидемиологические проявления ВИЧ-инфекции на территории Омской области за 2011 год. Информационный бюллетень / Под ред. О.И.Назаровой, О.В.Агафоновой. Омск: БУЗ Омской области «Центр по профилактике и борьбе со СПИД и инфекционными заболеваниями», 2012. 27 с. [Epidemiological manifestations of HIV infection in the territory of Omsk region in 2015. Newsletter. Eds. O.I.Nazarova, О.V.Agafonova. Omsk: Omsk Center for Prevention and Control of AIDS and Infectious Diseases, 2012, 27 p. (In Russ.)].
9. Российская база данных по рождаемости и смертности. Центр демографических исследований Российской экономической школы, Москва (Россия). URL: http://demogr.nes.ru/index.php/ru/demogr_indicat/data (Дата обращения 12.12.2016). [Russian data base on births and deaths. Center for demographic research, new economic school, Moscow (Russia). URL: http://demogr.nes.ru/index.php/ru/demogr_indicat/data (December 12, 2016) (In Russ.)].
10. Chiang C.L. Life table and mortality analysis. Geneva: World. Health Organization, 1978.
11. Wang H., Naghavi M., Allen C. et al. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet, 2016, Vol. 388, No. 10053, pp. 1459–1544. DOI: 10.1016/S0140-6736(16)31012-1.
12. Global Burden of Disease Study 2015 (GBD 2015) Reference Life Table. Seattle, United States: Institute for Health Metrics and Evaluation (IHME), 2016.
13. Ланг Т.А., Сесик М. Как описывать статистику в медицине. М.: Практическая медицина, 2011. [Lang T.A., Secic M. How to report statistics in medicine. Moscow: Practical Medicine, 2011 (In Russ.)].
14. Esteve J., Benhamou E., Raymond L. Statistical methods in cancer research. Vol. IV. Descriptive epidemiology. IARC Sci. publ., 1994, Vol. 128, No. 1, pp. 302.
15. Ortblad K.F., Lozano R., Murray C.J.L. The burden of HIV: insights from the Global Burden of Disease Study 2010. AIDS, 2013, Vol. 27 (13), pp. 2003–2017. DOI: 10.1097/QAD.0b013e328362ba67.
16. Oostvogels A.J., De Wit G.A., Jahn B., Cassini A., Colzani E., De Waure C. et al. Use of DALYs in economic analyses on interventions for infectious diseases: a systematic review. Epidemiol. Infect., 2015, Vol. 143 (9), pp. 1791–1802. DOI: 10.1017/S0950268814001940.
17. Noori A., Rahimzadeh S., Shahbazi M., Moradi G., Moghaddam S. et al. Burden of HIV in Iran: Insights from the Global Burden of Disease Study 2010. Archives of Iranian Medicine, 2016, Vol. 19, No. 5, pp. 329. URL: http://www.ams.ac.ir/AIM/NEWPUB/16/19/5/006.pdf.
18. Ock M., Lee J.Y., Oh I.H., Park H., Yoon S.J., Jo M.W. Disability-Adjusted Life Years for Communicable Disease in the Korean Burden of Disease Study 2012. J. Korean Med. Sci., 2016, Vol. 31, Suppl. 2, pp. S178–S183.
19. Aragón T.J., Lichtensztajn D.Y., Katcher B.S., Reiter R., Katz M.H. Calculating expected years of life lost for assessing local ethnic disparities in causes of premature death. BMC Public Health, 2008, Vol. 8, No. 1, pp. 116.
20. Teeraananchai S., Kerr S., Amin J., Ruxrungtham K., Law M. Life expectancy of HIV-positive people after starting combination antiretroviral therapy: a meta-analysis. HIV Med., No. 18, pp. 256–266. DOI: 10.1111/hiv.12421.
Review
For citations:
Blokh A.I., Pasechnik O.A. THE BURDEN OF DISEASE AND POTENTIAL LIFE LOSS DUE TO HIV INFECTION. HIV Infection and Immunosuppressive Disorders. 2017;9(3):91-97. (In Russ.) https://doi.org/10.22328/2077-9828-2017-9-3-91-97
Views:
1100
.png)
Email this article 